NEW YORK (GenomeWeb News) – Nanosphere today announced the closing of its public offering that raised $26.9 million in net proceeds.

The offering, announced last week, was of 12,075,000 shares of its common stock at a price of $2.40 per share, including 1,575,000 shares issued to underwriters' exercise in full of an overallotment option. Piper Jaffray was the sole book-running manager, and Roth Capital Partners was the co-manager of the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.